KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Work In Process (2016 - 2026)

CareDx's Work In Process history spans 11 years, with the latest figure at $3.6 million for Q1 2026.

  • On a quarterly basis, Work In Process fell 24.93% to $3.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.6 million, a 24.93% decrease, with the full-year FY2025 number at $3.7 million, down 1.4% from a year prior.
  • Work In Process hit $3.6 million in Q1 2026 for CareDx, down from $3.7 million in the prior quarter.
  • Over the last five years, Work In Process for CDNA hit a ceiling of $5.6 million in Q2 2025 and a floor of $3.5 million in Q1 2022.
  • Historically, Work In Process has averaged $4.5 million across 5 years, with a median of $4.3 million in 2022.
  • Biggest five-year swings in Work In Process: skyrocketed 52.26% in 2022 and later dropped 26.94% in 2024.
  • Tracing CDNA's Work In Process over 5 years: stood at $4.3 million in 2022, then grew by 20.55% to $5.2 million in 2023, then dropped by 26.93% to $3.8 million in 2024, then dropped by 1.4% to $3.7 million in 2025, then fell by 3.53% to $3.6 million in 2026.
  • Business Quant data shows Work In Process for CDNA at $3.6 million in Q1 2026, $3.7 million in Q4 2025, and $5.1 million in Q3 2025.